Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2023

Year

Stéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, Ombeline Empis de Vendin, Guillaume de Ciancio, Jean‐Benoît Arlet, Lina Khider, Béatrice Terriat, Hélène Greigert, Céline Robert,

EClinicalMedicine

Abstract

References